Cardiovascular Disease (CVD) Withdrawn Phase 4 Trials for Exenatide (DB01276)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00845559The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young AdultsTreatment